Skip to main content
. 2018 Dec 17;79(1):21–42. doi: 10.1007/s40265-018-1033-0

Fig. 4.

Fig. 4

Treatment algorithms for tumor control in neuroendocrine tumors (NETs). Summary of current medical strategies for tumor control in NETs according to the primary tumor site. Legend: Blue, red and green colors represent lung, pancreas and midgut NETs respectively. SSTR somatostatin receptor expression, SSA somatostatin analog, PRRT peptide receptor radionuclide therapy. *Not registered for this indication, **PRRT has been approved in Europe for midgut NETs and in the USA for midgut and pancreatic NETs, ***streptozocin/5-fluorouracil or streptozocin/doxorubicin; temozolomide/capecitabine as an alternative regimen